Glutamatergic mechanisms of comorbidity between acute stress and cocaine self-administration

Molecular Psychiatry

Volumn 21, Issue 8, 2016, Pages 1063-1069

  Garcia Keller, C ^a,b   Kupchik, Y M ^c   Gipson, C D ^a   Brown, R M ^d   Spencer, S ^a   Bollati, F ^b   Esparza, M A ^b   Roberts Wolfe, D J ^a   Heinsbroek, J A ^a   Bobadilla, A C ^a   Cancela, L M ^b   Kalivas, P W ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b UNIVERSIDAD NACIONAL DE CÓRDOBA   (Argentina)

^c HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^d UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; CEFTRIAXONE; COCAINE; GLUTAMATE TRANSPORTER; AMINO ACID RECEPTOR AFFECTING AGENT; CENTRAL STIMULANT AGENT; GLUTAMIC ACID;

ACUTE STRESS DISORDER; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL STRUCTURE; COCAINE DEPENDENCE; COMORBIDITY; CONTROLLED STUDY; DENDRITIC SPINE; DRUG SELF ADMINISTRATION; GLUTAMATERGIC SYNAPSE; IMMOBILIZATION STRESS; LOCOMOTION; MALE; NONHUMAN; NUCLEUS ACCUMBENS CORE; PRIORITY JOURNAL; RAT; WESTERN BLOTTING; ANIMAL; COCAINE-RELATED DISORDERS; DRUG EFFECTS; MENTAL STRESS; METABOLISM; NUCLEUS ACCUMBENS; PROCEDURES; PSYCHOLOGY; REINFORCEMENT; SPRAGUE DAWLEY RAT; SYNAPSE;

ANIMALS; CEFTRIAXONE; CENTRAL NERVOUS SYSTEM STIMULANTS; COCAINE; COCAINE-RELATED DISORDERS; COMORBIDITY; DENDRITIC SPINES; EXCITATORY AMINO ACID AGENTS; EXTINCTION, PSYCHOLOGICAL; GLUTAMIC ACID; MALE; NUCLEUS ACCUMBENS; RATS; RATS, SPRAGUE-DAWLEY; SELF ADMINISTRATION; STRESS, PSYCHOLOGICAL; SYNAPSES;

EID: 84979220561     PISSN: 13594184     EISSN: 14765578     Source Type: Journal    
DOI: 10.1038/mp.2015.151     Document Type: Article

References (56)

1. Seal KH, Metzler TJ, Gima KS, Bertenthal D, Maguen S, Marmar CR. Trends and risk factors for mental health diagnoses among Iraq and Afghanistan veterans using Department of Veterans Affairs health care, 2002-2008. Am J Public Health 2009; 99: 1651-1658.
2. Kessler RC, Chiu WT, Demler O, Merikangas KR, Walters EE. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005; 62: 617-627.
3. Boden MT, Kimerling R, Jacobs-Lentz J, Bowman D, Weaver C, Carney D, et al. Seeking safety treatment for male veterans with a substance use disorder and post-Traumatic stress disorder symptomatology. Addiction 2012; 107: 578-586.
4. Seal KH, Bertenthal D, Miner CR, Sen S, Marmar C. Bringing the war back home: mental health disorders among 103, 788 US veterans returning from Iraq and Afghanistan seen at Department of Veterans Affairs facilities. Arch Int Med 2007; 167: 476-482.
5. Shaham Y, Stewart J. Exposure to mild stress enhances the reinforcing efficacy of intravenous heroin self-Administration in rats. Psychopharmacology 1994; 114: 523-527.
6. Esparza MA, Bollati F, Garcia-Keller C, Virgolini MB, Lopez LM, Brusco A, et al. Stress-induced sensitization to cocaine: actin cytoskeleton remodeling within mesocorticolimbic nuclei. Eur J Neurosci 2012; 36: 3103-3117.
7. Garcia-Keller C, Martinez SA, Esparza MA, Bollati F, Kalivas PW, Cancela LM. Crosssensitization between cocaine and acute restraint stress is associated with sensitized dopamine but not glutamate release in the nucleus accumbens. Eur J Neurosci 2013; 37: 982-995.
8. Miczek KA, Mutschler NH. Activational effects of social stress on IV cocaine selfadministration in rats. Psychopharmacology 1996; 128: 256-264.
9. Sorg BA, Kalivas PW. Behavioral and neurochemical cross-sensitization between footshock stress and cocaine. Brain Res 1991; 559: 29-36.
10. Goeders NE, Guerin GF. Non-contingent electric footshock facilitates the acquistion of intravenous cocaine self-Adminstration in rats. Psychopharmacology 1994; 114: 63-70.
11. Cohen H, Kozlovsky N, Alona C, Matar MA, Joseph Z. Animal model for PTSD: from clinical concept to translational research. Neuropharmacology 2012; 62: 715-724.
12. Daskalakis NP, Yehuda R, Diamond DM. Animal models in translational studies of PTSD. Psychoneuroendocrinology 2013; 38: 1895-1911.
13. Piazza PV, Deroche-Gamonet V. A general theory of transition to addiction it was and a general theory of transition to addiction it is : reply to the commentaries of Ahmed, Badiani, George & Koob, Kalivas & Gipson, and Tiffany. Psychopharmacology (Berl) 2014; 231: 3929-3937.
14. Bonci A, Borgland S. Role of orexin/hypocretin and CRF in the formation of drugdependent synaptic plasticity in the mesolimbic system. Neuropharmacology 2009; 56: 107-111.
15. Ungless MA, Singh V, Crowder TL, Yaka R, Ron D, Bonci A. Corticotropin-releasing factor requires CRF binding protein to potentiate NMDA receptors via CRF receptor 2 in dopamine neurons. Neuron 2003; 39: 401-407.
16. Wang B, You ZB, Rice KC, Wise RA. Stress-induced relapse to cocaine seeking: roles for the CRF(2) receptor and CRF-binding protein in the ventral tegmental area of the rat. Psychopharmacology (Berl) 2007; 193: 283-294.
17. Wang B, You ZB, Wise RA. Heroin self-Administration experience establishes control of ventral tegmental glutamate release by stress and environmental stimuli. Neuropsychopharmacology 2012; 37: 2863-2869.
18. Belujon P, Grace AA. Hippocampus, amygdala, and stress: interacting systems that affect susceptibility to addiction. Ann NY Acad Sci 2011; 1216: 114-121.
19. Bagot RC, Parise EM, Pena CJ, Zhang HX, Maze I, Chaudhury D, et al. Ventral hippocampal afferents to the nucleus accumbens regulate susceptibility to depression. Nat Commun 2015; 6: 7062.
20. Conrad KL, Tseng KY, Uejima JL, Reimers JM, Heng LJ, Shaham Y, et al. Formation of accumbens GluR2-lacking AMPA receptors mediates incubation of cocaine craving. Nature 2008; 454: 118-121.
21. Kourrich S, Rothwell PE, Klug JR, Thomas MJ. Cocaine experience controls bidirectional synaptic plasticity in the nucleus accumbens. J Neurosci 2007; 27: 7921-7928.
22. Trantham-Davidson H, LaLumiere RT, Reissner KJ, Kalivas PW, Knackstedt LA. Ceftriaxone normalizes nucleus accumbens synaptic transmission, glutamate transport, and export following cocaine self-Administration and extinction training. J Neurosci 2012; 32: 12406-12410.
23. Russo SJ, Dietz DM, Dumitriu D, Morrison JH, Malenka RC, Nestler EJ. The addicted synapse: mechanisms of synaptic and structural plasticity in nucleus accumbens. Trends Neurosci 2010; 33: 267-276.
24. Robinson TE, Kolb B. Structural plasticity associated with exposure to drugs of abuse. Neuropharmacology 2004; 47: 33-46.
25. Pan H-T, Menacherry L, Justice JB. Differences in the pharmacokinetics of cocaine in naive and cocaine-experienced rats. J Neurochem 1991; 56: 1299-1306.
26. Knackstedt LA, Melendez RI, Kalivas PW. Ceftriaxone restores glutamate homeostasis and prevents relapse to cocaine seeking. Biol Psychiatry 2010; 67: 81-84.
27. Dunkley PR, Jarvie PE, Robinson PJ. A rapid Percoll gradient procedure for preparation of synaptosomes. Nat Protoc 2008; 3: 1718-1728.
28. Stigliani S, Zappettini S, Raiteri L, Passalacqua M, Melloni E, Venturi C, et al. Glia re-sealed particles freshly prepared from adult rat brain are competent for exocytotic release of glutamate. J Neurochem 2006; 96: 656-668.
29. Shen HW, Scofield MD, Boger H, Hensley M, Kalivas PW. Synaptic glutamate spillover due to impaired glutamate uptake mediates heroin relapse. J Neurosci 2014; 34: 5649-5657.
30. Shen H, Moussawi K, Zhou W, Toda S, Kalivas PW. Heroin relapse requires longterm potentiation-like plasticity mediated by NMDA2b-containing receptors. Proc Natl Acad Sci USA 2011; 108: 19407-19412.
31. Shen HW, Toda S, Moussawi K, Bouknight A, Zahm DS, Kalivas PW. Altered dendritic spine plasticity in cocaine-withdrawn rats. J Neurosci 2009; 29: 2876-2884.
32. Wolf ME, Ferrario CR. AMPA receptor plasticity in the nucleus accumbens after repeated exposure to cocaine. Neurosci Biobehav Rev 2011; 35: 185-211.
33. Kalivas PW. The glutamate homeostasis hypothesis of addiction. Nat Rev Neurosci 2009; 10: 561-572.
34. Gipson CD, Reissner KJ, Kupchik YM, Smith AC, Stankeviciute N, Hensley-Simon ME, et al. Reinstatement of nicotine seeking is mediated by glutamatergic plasticity. Proc Natl Acad Sci USA 2013; 110: 9124-9129.
35. Rao PS, Sari Y. Glutamate transporter 1: target for the treatment of alcohol dependence. Curr Med Chem 2012; 19: 5148-5156.
36. Danbolt NC. Glutamate uptake. Prog Neurobiol 2001; 65: 1-105.
37. Sari Y, Sakai M, Weedman JM, Rebec GV, Bell RL. Ceftriaxone, a beta-lactam antibiotic, reduces ethanol consumption in alcohol-preferring rats. Alcohol Alcohol 2011; 46: 239-246.
38. Alhaddad H, Das SC, Sari Y. Effects of ceftriaxone on ethanol intake: a possible role for xCT and GLT-1 isoforms modulation of glutamate levels in P rats. Psychopharmacology (Berl) 2014; 231: 4049-4057.
39. Reissner KJ, Gipson CD, Tran PK, Knackstedt LA, Scofield MD, Kalivas PW. Glutamate transporter GLT-1 mediates N-Acetylcysteine inhibition of cocaine reinstatement. Addict Biol 2014; 20: 316-323.
40. Rothstein JD, Patel S, Regan MR, Haenggeli C, Huang YH, Bergles DE, et al. Betalactam antibiotics offer neuroprotection by increasing glutamate transporter expression. Nature 2005; 433: 73-77.
41. Minelli A, Barbaresi P, Reimer RJ, Edwards RH, Conti F. The glial glutamate transporter GLT-1 is localized both in the vicinity of and at distance from axon terminals in the rat cerebral cortex. Neuroscience 2001; 108: 51-59.
42. Cholet N, Pellerin L, Magistretti PJ, Hamel E. Similar perisynaptic glial localization for the Na+, K+-ATPase alpha 2 subunit and the glutamate transporters GLAST and GLT-1 in the rat somatosensory cortex. Cereb Cortex 2002; 12: 515-525.
43. Gipson CD, Kupchik YM, Shen H, Reissner KJ, Thomas CA, Kalivas PW. Relapse induced by cues predicting cocaine depends on rapid, transient synaptic potentiation. Neuron 2013; 77: 867-872.
44. Vialou V, Robison AJ, Laplant QC, Covington HE 3rd, Dietz DM, Ohnishi YN, et al. DeltaFosB in brain reward circuits mediates resilience to stress and antidepressant responses. Nat Neurosci 2010; 13: 745-752.
45. Christoffel DJ, Golden SA, Walsh JJ, Guise KG, Heshmati M, Friedman AK, et al. Excitatory transmission at thalamo-striatal synapses mediates susceptibility to social stress. Nat Neurosci 2015; 18: 962-964.
46. Lim BK, Huang KW, Grueter BA, Rothwell PE, Malenka RC. Anhedonia requires MC4R-mediated synaptic adaptations in nucleus accumbens. Nature 2012; 487: 183-189.
47. Marinelli M, Piazza PV. Interaction between glucocorticoid hormones, stress and psychostimulant drugs. Eur J Neurosci 2002; 16: 387-394.
48. de Jong IE, de Kloet ER. Glucocorticoids and vulnerability to psychostimulant drugs: toward substrate and mechanism. Ann NY Acad Sci 2004; 1018: 192-198.
49. Ambroggi F, Turiault M, Milet A, Deroche-Gamonet V, Parnaudeau S, Balado E, et al. Stress and addiction: glucocorticoid receptor in dopaminoceptive neurons facilitates cocaine seeking. Nat Neurosci 2009; 12: 247-249.
50. Tagliaferro P, Morales M. Synapses between corticotropin-releasing factor-containing axon terminals and dopaminergic neurons in the ventral tegmental area are predominantly glutamatergic. J Comp Neurol 2008; 506: 616-626.
51. Wang B, Shaham Y, Zitzman D, Azari S, Wise RA, You ZB. Cocaine experience establishes control of midbrain glutamate and dopamine by corticotropinreleasing factor: a role in stress-induced relapse to drug seeking. J Neurosci 2005; 25: 5389-5396.
52. Chen NA, Jupp B, Sztainberg Y, Lebow M, Brown RM, Kim JH, et al. Knockdown of CRF1 receptors in the ventral tegmental area attenuates cue- And acute food deprivation stress-induced cocaine seeking in mice. J Neurosci 2014; 34: 11560-11570.
53. Cole BJ, Cador M, Stinus L, Rivier C, Rivier J, Vale W, et al. Critical role of the hypothalamic pituitary adrenal axis in amphetamine-induced sensitization of behavior. Life Sci 1990; 47: 1715-1720.
54. Boyson CO, Miguel TT, Quadros IM, Debold JF, Miczek KA. Prevention of social stress-escalated cocaine self-Administration by CRF-R1 antagonist in the rat VTA. Psychopharmacology (Berl) 2011; 218: 257-269.
55. Sofuoglu M, Rosenheck R, Petrakis I. Pharmacological treatment of comorbid PTSD and substance use disorder: recent progress. Addict Behav 2014; 39: 428-433.
56. Berk M, Malhi GS, Gray LJ, Dean OM. The promise of N-Acetylcysteine in neuropsychiatry. Trends Pharmacol Sci 2013; 34: 167-177.